IMMUNODEFICIENCY-VIRUS
Top PDF IMMUNODEFICIENCY-VIRUS:
Quality of Health Care and Viral Suppression Among Human Immunodeficiency Virus Patients
... Background: In Mexico, the quality of health care for human immunodeficiency virus (HIV) patients is unknown. The study objectives were to develop quality of care (QoC) indicators for outpatient care of HIV ...
9
Profound CD4+ T lymphocytopenia in human immunodeficiency virus negative individuals, improved with anti human herpes virus treatment
... human immunodeficiency virus, is the most frequently ...Barr virus can be associated with transient lymphocytopenia and CD4+ T ...herpes virus has not been ...human immunodeficiency ...
7
In vitro binding of simian immunodeficiency virus matrix protein to the cytoplasmic domain of the envelope glycoprotein
... simian immunodeficiency virus (SIV) particles is mediated by the association of the Env cytoplasmic domain (CD) with the matrix (MA) domain of ...human immunodeficiency virus type 1 Env CD, ...
7
Feline immunodeficiency virus infection: A comparative study of different diagnostic techniques
... feline immunodeficiency virus (FIV) by Pedersen (1987) in the United States and the availability of diagnostic tests, FIV has been identified in many other countries including the United Kingdom (Harbour et ...
6
Predictors of chronic liver disease in individuals with human immunodeficiency virus infection
... Introduction. Chronic liver disease (CLD) is becoming a major cause of mortality in patients who are positi- ve with human immunodeficiency virus (HIV). Our aim was to assess the prevalence of CLD in HIV+ ...
5
Human Immunodeficiency Virus infection, asymptomatic atherosclerosis, and inflammation: A candidate gene study
... The anti-viral immunity and cytokine production started in the acute phase of HIV infection continues into the chronic phase. The cellular and humoral immune responses keep viral load to constant levels maintaining a ...
199
Interatrial blocks prevalence and risk factors for human immunodeficiency virus infected persons
... We codified toxic habits in an ordinal way (current, former, or never) while comorbidities were registered on a presence/absence basis. Hepatitis C virus infection (HCV) was defined as detectable viremia or a ...
12
Module XlTreatment of HCV and HIV coinfection
... HCV and human immunodeficiency virus (HIV) coin- fection is common in patients who acquire HIV by parenteral routes. Increased survival rates in patients with HIV resulting from the use of highly active ...
7
Uvetis sifiltica asociada al virus de inmunodeficiencia humana
... in the secondary, latent or tertiary phase and in a bilateral form in 50% of the cases, it may be associated with the human immunodeficiency virus. Since the introduction of the highly active antiretroviral ...
7
VIH en la terapia intensiva
... ABSTRACT. In the 1980s, AIDS was considered to be uniformly fatal. Highly active antiretroviral therapy (HAART) has proven effective in reducing morbidity and mortality associated with human immunodeficiency ...
6
Biochemical non invasive assessment of liver fibrosis cannot replace biopsy in HIV HCV coinfected patients
... human immunodeficiency virus (HIV)/hepatitis C virus (HCV) coinfected patients, and compare to AST/ALT ratio (AAR), AST to platelet ratio index (APRI) and FIB-4 scores, as a tool for the assessment ...
6
Dimerization inhibitors of HIV 1 reverse transcriptase, protease and integrase: A single mode of inhibition for the three HIV enzymes?
... human immunodeficiency virus type 1 (HIV-1) encodes 15 distinct proteins, three of which provide essential enzymatic functions: a reverse transcriptase (RT), an integrase (IN), and a protease ...
8
fiebre sida 2
... 11. Lozano F, Tirre-Cisneros J, Bascunana A, et al. Prospective evaluation of 25. Supparatpinyo K, Kwamwan C, Baosoung V, et al. Disseminated Penicil- fever of unknown origin in patients infected with the human immunode- ...
5
Quality of life in persons living with HIV–AIDS in three healthcare institutions of Cali, Colombia
... Human Immunodeficiency Virus-Infected Individuals (PLWHA); this has led healthcare providers and researchers to make measurements of the health and wellbeing of individuals in very limited manner 4 ...
9
2020.05.03.18
... Abstract: Nowadays, the application of alternative methods instead of clinical treatment creates a new possibility to prevent the development of diseases. Medicinal plants such as Sambucus nigra have been well known due ...
7
Patrn de la enfermedad y sobrevida en nios y adolescentes infectados por VIH manejados con terapia antirretroviral altamente activa
... Results. 202 HIV-infected children and adolescents were seen under HAART or without HAART ( ³ 6 months). Of all patients, the time since diagnosis of acquired immunodeficiency syndrome (AIDS) was on average 37.3 ...
11
Inducción de inmunidad en mucosas contra el VIH mediante la secreción del ASA V3 fusionada a la subunidad A2B de la toxina del cólera en Lactococcus lactis
... El VIH es un retrovirus que, gracias a la interacción de la glicoproteína gp 120 de su membrana con los receptores celulares como el CD4, y los dos más bien definidos correceptores celulares CXCR4 y CCR5, miembros de las ...
149
Estudio de los cambios virológicos y de inmunidad celular en tejido amigdalar tras tratamiento antiretroviral en pacientes infectados por HIV en estado temprano de la infección
... Desde la primera descripción del Síndrome de la Inmunodeficiencia humana Adquirida (SIDA) en 1981(1-3), se han buscado parámetros objetivos que sirvieran para constatar el control clínico y realizar el seguimiento y el ...
309
Estudi del virus de la inmunodeficiència humana tipus 1 (VIH-1) en pacients infectats crònics sotmesos a interrupcions estructurades del tractament (IET).
... primària, i un elevat grau d’homogeneïtat de la quasiespècie vírica present en l’individu al llarg del temps (Delwart, 1997). Aquestes característiques són probablement el reflex d’una resposta immunològica pobre per ...
233
Estratègies de simplificació del tractament antiretroviral en diferents estadiatges de la infecció pel VIH-1
... Les interrupcions parcials del tractament redueixen l’exposició als fàrmacs mantenint solament aquells amb activitat residual. L’objectiu és disminuir el nombre de comprimits i les toxicitats mitjançant la discontinuació ...
213